Table 2.
Major disease groups evaluated per year
| Exam Year | 2013 | 2014 | 2015 | 2016 |
| Disease Type | n (%) | n(%) | n (%) | n(%) |
| Congenital | 2 (1.0) | 14(6.7) | 1(0.5) | 2 (1.0) |
|
Connective Tissues/ Autoimmune |
0 | 0 | 1(0.5) | 1(0.5) |
| Degenerative | 90(42.9%) | 98(46.7) | 123(58.6) | 102(48.6) |
| Inflammatory/ Infection | 10(4.8) | 0 | 5 (2.4) | 7(3.3) |
| Metabolic/ Endocrine | 1(0.5) | 0 | 0 | 1(0.5) |
| Neoplasia-Benign | 2(1.0) | 0 | 2(1) | 4(1.9) |
| Neoplasia-Malignant | 11(5.2) | 17(8.1) | 13(6.2) | 19(9.0) |
| Neurodegenerative | 0 | 0 | 0 | 1(0.5) |
| Nonspecific | 18(8.6) | 24(11.4) | 17(8.1) | 23(11.0) |
| Others | 32(15.2) | 27(12.9) | 19(9.0) | 23(11.0) |
| Trauma | 27(12.9) | 20(9.5%) | 18(8.6) | 14(6.7) |
| Vascular | 17(8.1) | 10(4.8%) | 11(5.2) | 13(6.2) |
| Total | 210(100) | 210(100) | 210(100) | 210 (100) |